行情

LCI

LCI

Lannett Co
NYSE

实时行情|Nasdaq Last Sale

14.00
+0.23
+1.67%
盘后: 14.06 +0.06 +0.43% 16:00 09/18 EDT
开盘
13.83
昨收
13.77
最高
14.03
最低
13.45
成交量
128.50万
成交额
--
52周最高
15.52
52周最低
3.330
市值
5.65亿
市盈率(TTM)
-1.9262
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

LCI 新闻

  • 连续三天!美联储计划再进行750亿美元隔夜回购操作
  • 新浪财经综合.45分钟前
  • 微软宣布400亿美元股票回购 盘后股价上涨1.3%
  • 新浪美股.58分钟前
  • 新iPhone预售“真香” 苹果公司却一年痛失三位高管
  • 新浪美股.1小时前
  • 罢工导致工厂放缓 通用汽车在加拿大临时裁员1200人
  • 新浪美股.1小时前

更多

所属板块

制药
0.00%
制药与医学研究
-0.14%

热门股票

名称
价格
涨跌幅

LCI 简况

Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc. As of June 30, 2016, the Company's products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules. The Company has additional products under development, which are orally administered solid oral-dosage products (tablet/capsule) or oral solutions, nasal, topicals or parentarels, as well as other dosage forms.
展开

Webull提供Lannett Company, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。